Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Class A Common Stock, $0.0001 par value per share · CUSIP: 68277Q105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Lundbeckfond Invest A/S
Shares: 203,122.00 · Class: 1.6%
- Lene Skole
Shares: 203,122.00 · Class: 1.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-003306
- Form type
- SCHEDULE 13G/A
- Filer
- Lundbeckfond Invest A/S
- CIK
- CIK 1591046
- Filed
- Feb 06, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership